A Catalyst for Change: The European Cancer Patient's Bill of Rights
Mark Lawler(Queen's University Belfast), Patrick G. Johnston(Queen's University Belfast), Peter Johnson(University of California, San Francisco), David Cameron(Edinburgh Cancer Research), Filippo de Braud(University of Milan), Richard Sullivan(King's College London), Denis Horgan, Kathy Oliver(European CanCer Organisation), Josep Tabernero(Universitat de Vic - Universitat Central de Catalunya), R. Wilson, Nils Wilking(Karolinska Institutet), Pierfranco Conté(University of Padua), Sema Erdem(European CanCer Organisation), Sarper Diler(Myeloma UK), Martin J. Murphy(Virginia Commonwealth University), Bob Löwenberg(Erasmus MC), Peter Kapitein, Michèle Barzach(Institut de Chirurgie Guidée par l'Image), Joan Kelly(Irish Cancer Society), Aimery de Gramont(Institut Hospitalier Franco Britannique), Mariano Barbacid(Spanish National Cancer Research Centre), Jan Geißler, Gerlind Bode, Jonas Bergh(Karolinska University Hospital), Liselotte Højgaard(University of Copenhagen), Francesco De Lorenzo(European CanCer Organisation), Sandra Kloezen(Dutch Cancer Society), Carlo La Vecchia(University of Milan), Harald zur Hausen(German Cancer Research Center), Ian Banks(European Disability Forum), Christoph Zielinski(Vienna General Hospital), Peter J. Selby(Blood Cancer UK), John M. Fitzpatrick(Mater Misericordiae University Hospital), Volker Diehl(University of Cologne), Donal Hollywood(Trinity College Dublin), Jean‐Pierre Armand(Institut Curie), Thierry Le Chevalier(Institut Gustave Roussy), Françoise Meunier, H. M. Pinedo(European Organisation for Research and Treatment of Cancer), Cornelis JH van de Velde(Leiden University), Jacek Jassem
Cited by 46
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k